Zentiva Pharma UK Limited

The large node is Zentiva Pharma UK Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.

Who leads it

Previous officers 24

Directors and secretaries as filed at Companies House.

Do you help lead this organisation? Set up its network · How it works

From Contracts Finder and Find a Tender, the UK Government's public procurement notices, under the Open Government Licence v3.0. Matched to this organisation by company number, charity number or exact name and postcode; every figure links to its source notice.

• NHS National Generic Pharmaceuticals - Wave 16a Buyer: NHS England £15,529,352 2026-08-27 Source: Find a Tender

  NHS National Framework for Generics Pharmaceuticals Wave 16a Offer reference number: CM/PHG/24/5714 Period of framework agreement: Dates detailed below, with an option or options to extend (at the authority’s discretion) for a period or per…

  Framework
• Anti-Infective Drugs 3 Buyer: Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards Value not published Date not published CPV 33600000 Source: Find a Tender

  Generic Anti-Infective Drugs
• Oncology Generics Medicines Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") Value not published Date not published CPV 33600000 Source: Find a Tender

  This Framework Agreement is for the supply of Oncology Generic medicines to NHS Scotland. The Goods have been separated into thirty-nine (39) categories, each of which is identified as a “Lot”. Full details of each Lot is contained in secti…

  Framework
• Oncology Generics Medicines Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") Value not published Date not published CPV 33600000 Source: Find a Tender

  This Framework Agreement is for the supply of Oncology Generic medicines to NHS Scotland. The Goods have been separated into thirty-nine (39) categories, each of which is identified as a “Lot”. Full details of each Lot is contained in secti…

  Framework
• NHS National Generic Pharmaceuticals Interim 2 2020 Buyer: The NHS Commissioning Board (operating under the name of NHS England) Value not published Date not published CPV 33690000 Source: Find a Tender

  Hospital only products - All regions:01/02/2021 to 31/01/2022Orals (plus non-parenterals) – Allregions: 01/03/2021 to 28/02/202212 months with an option or options toextend (at the Authority’s discretion) fora period or periods up to a tota…

  Framework
• NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide Buyer: NHS England Value not published Date not published Source: Find a Tender

  NHS National Framework for Lenalidomide, Pomalidomide & Thalidomide. Offer reference number: CM/PHG/24/5716 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a …

  Framework
• NHS National Branded Interim - 1 June 2026 Buyer: NHS England Value not published Date not published Source: Find a Tender

  Provision of an NHS National Branded Interim - 1 June 2026 01/06/2026 - 30/04/2028 23 Months with an option or options to extend at the discretion of the authority up to a maximum of 25 months

  Framework
• NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 Buyer: NHS England Value not published Date not published Source: Find a Tender

  NHS Branded Medicines Tranche B - Lot 1 - London & South of England - CM/PHR/25/5731 Period of Framework Agreement: 1 September 2026 to 31 August 2028 with an option or option(s) to extend (at the Authority’s discretion) for a period or per…

  Framework
• NHS National Generics Pharmaceuticals - Supply Chain Resilience Buyer: NHS England Value not published Date not published Source: Find a Tender

  NHS National Generics Pharmaceuticals - Supply Chain Resilience Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months…

  Framework
• Generic, Branded Generic & Proprietary Medicinal Products - Group 18 Buyer: Regional Business Services Organisation, Procurement and Logistics Service Value not published Date not published CPV 33600000 Source: Find a Tender

  Generic, Branded Generic & Proprietary Medicinal Products - Group 18 (6345404)
• Contraceptive Medicines Buyer: The Common Services Agency (more commonly known as Public Services Delivery Scotland (PSDS) Value not published Date not published CPV 33600000 Source: Find a Tender

  This Framework Agreement is for the supply of Contraceptive Medicines to health boards across NHS Scotland. The Goods have been split into five (5) categories, each of which is identified as a "Lot". Full details of each Lot is contained in…

About

What it does

Wholesale of pharmaceutical goods

Incorporated

28/08/1987

Registered office

London

Previous names

Winthrop Pharmaceuticals UK Limited (until 05/07/2018)

Ownership

Group

1. Zentiva Pharma UK Limited is controlled by Aventis Pharma Limited
   Evidence

   ceased 75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06, ceased 2018-09-30 · source: Companies House PSC register
2. Aventis Pharma Limited is controlled by Sanofi-Aventis UK Holdings Limited
   Evidence

   active 75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 · source: Companies House PSC register
3. Sanofi-Aventis UK Holdings Limited is controlled by Sanofi-Synthelabo UK Limited
   Evidence

   active 25-50% shares, 25-50% voting · notified 2016-04-06 · source: Companies House PSC register

Ultimately controlled by Sanofi-Synthelabo UK Limited.

Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.

Financials

Net assets

£7,556,000

Total assets

£45,217,000

Employees

51

Turnover

£119,349,000

Profit/loss

-£791,000

Figures from accounts filed at Companies House (iXBRL), period ending 2025-12-31. Where turnover is absent, small and micro-entity accounts are not required to report it, so it is not shown as zero.

Sources

Official record from Companies House. Governance Register calculates the connections.